Concepedia

Linda A. Kroger

LA

Statistics

Publications

36

Citations

1.6K

H-Index

25

Active since

1991

Affiliations

University of California Davis Medical Center(Current)

University of California, Davis

Palmetto Hematology Oncology

University of California, San Francisco

VA Northern California Health Care System

Linda A. Kroger is an author at University of California Davis Medical Center specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

1991–2003

36

Publications

36

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein et al. · Journal of Clinical Oncology · 1998 · 182 citations

Osteitis Caused by Bacille Calmette-Guerin Vaccination: A Retrospective Analysis of 222 Cases

Linda A. Kroger, Matti Korppi, E Brander et al. · The Journal of Infectious Diseases · 1995 · 121 citations

, , +6

Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: Efficacy and toxicity in breast cancer xenografts

Sally J. DeNardo, David L. Kukis, Linda A. Kroger et al. · Proceedings of the National Academy of Sciences · 1997 · 109 citations · Full text

Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using <sup>131</sup> I-LYM-1 Antibody

Gerald L. DeNardo, Sally J. DeNardo, Kathleen R. Lamborn et al. · Cancer Biotherapy and Radiopharmaceuticals · 1998 · 95 citations

67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.

Sally J. DeNardo, Gerald L. DeNardo, David L. Kukis et al. · PubMed · 1999 · 65 citations

1–5 of 36